AMGEN INC (AMGN) vs PFIZER INC (PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | AMGN | PFE |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $36.75B | $62.58B |
| Revenue growth (YoY) | ▲ 10.0% | ▼ 1.6% |
| Net income | $7.71B | $7.77B |
| Gross margin | 67.2% | 74.3% |
| Diluted EPS | $14.23 | $1.36 |
| Insider net (6 mo) | +6.3K sh • 4 sells • 0 buys | +109.6K sh • 2 sells • 3 buys |
| Institutional owners | 59 | 56 |
| Institutional value held | $116.3B | $64.11B |
| Next earnings (est.) | Feb 2, 2027 | Feb 2, 2027 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About AMGEN INC (AMGN)
Amgen Inc. discovers, develops, manufactures and delivers innovative human therapeutics aimed at serious diseases, with a focus on areas of high unmet medical need. Read more →
About PFIZER INC (PFE)
Pfizer Inc. is a research-based global biopharmaceutical company, incorporated in Delaware in 1942. Read more →
Source: SEC EDGAR.